TP53突变在前列腺癌发生发展以及治疗与预后评估中作用的研究进展
Research progress on the role of TP53 mutation in the occurrence,development,treatment,and prognosis evaluation of prostate cancer
汪正斌 1温诚浩 1张力2
作者信息
- 1. 安徽医科大学第一附属医院泌尿外科安徽医科大学泌尿外科研究所泌尿生殖系统疾病安徽省重点实验室(合肥,230022)
- 2. 安徽医科大学第一附属医院泌尿外科安徽医科大学泌尿外科研究所泌尿生殖系统疾病安徽省重点实验室(合肥,230022);安徽医科大学第一附属医院科研实验中心
- 折叠
摘要
前列腺癌(prostate cancer,PCa)是男性泌尿生殖系最常见的恶性肿瘤之一,其发病率及死亡率近年来逐渐升高.研究表明肿瘤抑制基因TP53突变在PCa中起着重要作用,TP53突变后形成突变型TP53,其表达产物突变型P53蛋白即失去原有的抑癌作用.因此,探究TP53基因突变在PCa发生与进展等方面中的作用,进而以TP53突变为靶点治疗PCa逐渐成为研究热点,这对于延长PCa患者生存期可能具有重要的临床意义.本文就TP53基因突变在PCa发生发展以及治疗与预后评估中作用的研究进展作一综述.
Abstract
Prostate cancer is one of the most frequently malignant tumors in male genitourinary system,and its morbidity and mortality have gradually increased in recent years.A large number of studies have shown that the mutation of tumor suppressor gene TP53 plays an important role in PCa.Mutant TP53 is formed after mutation of TP53,and its expression product mutant P53 protein loses its original anti-tumor effect.Therefore,to explore the role of TP53 gene mutation in the occurrence and progression of PCa,and then treat PCa by targeting TP53 mutation has gradually become a research hotspot,which may have important clinical significance for prolonging the survival of PCa patients.This article reviews the research progress on the role of TP53 gene mutation in the occurrence,development,treatment,and prognosis evaluation of PCa.
关键词
前列腺癌/TP53基因/突变Key words
prostate cancer/TP53 gene/mutation引用本文复制引用
出版年
2024
NETL
NSTL
万方数据